Fidelity Investments
CADX

Fidelity Investments’s CADENCE PHARMACEUTICALS, INC COM STK CADX Stock Holding History

Fidelity Investments’s Portfolio CADX Stock Details CADX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,920,475
Closed -$26.4M – 2784
2013
Q4 		$26.4M Sell
2,920,475
-4,704,517
-62% -$34M ﹤0.01% 1598
2013
Q3 		$48.1M Sell
7,624,992
-696,751
-8% -$4.43M 0.01% 1297
2013
Q2 		$56.8M Buy
+8,321,743
New +$58M 0.01% 1188

Other funds holding CADX

OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Fidelity Investments's CADX Position: Q1 2014 in Review

Fidelity Investments sold out of CADENCE PHARMACEUTICALS, INC COM STK (CADX) in Q1 2014, closing a stake of 2,920,475 shares — an estimated $26.4M sold.

Fidelity Investments first reported a position in CADX in Q2 2013 and held it in 3 quarters. The position peaked at $56.8M in Q2 2013. 3 funds tracked by Wall St. Rank hold CADX as of Q1 2014.

  • Fidelity Investments reported no remaining CADENCE PHARMACEUTICALS, INC COM STK position as of Q1 2014 after selling out during the quarter.
  • Fidelity Investments sold 2,920,475 CADENCE PHARMACEUTICALS, INC COM STK shares in Q1 2014, an estimated $26.4M.
  • Fidelity Investments first reported a position in CADENCE PHARMACEUTICALS, INC COM STK in Q2 2013 and held it in 3 quarters.
  • Fidelity Investments's CADENCE PHARMACEUTICALS, INC COM STK position peaked at $56.8M in Q2 2013.
  • 3 funds tracked by Wall St. Rank held CADENCE PHARMACEUTICALS, INC COM STK as of Q1 2014.

Based on Fidelity Investments's 13F filing for Q1 2014, filed 15 May 2014.